SUCNR1-IN-2 (Statement 35) is a succinate/succinate receptor 1 inhibitor for the study of neurodegenerative diseases such as neuroinflammation[1].
References:
[1]. Xin Li, et al. Targeting sucnr1 to reduce neuroinflammation. Patent US20230293504A1.
SUCNR1-IN-2 (Statement 35) is a succinate/succinate receptor 1 inhibitor for the study of neurodegenerative diseases such as neuroinflammation[1].
References:
[1]. Xin Li, et al. Targeting sucnr1 to reduce neuroinflammation. Patent US20230293504A1.